miR-421, miR-155 and miR-650: Emerging trends of regulation of cancer and apoptosis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 5, 2014, Pages 1909-1912

  Farooqi, Ammad Ahmad ^a   Qureshi, Muhammad Zahid ^a   Coskunpinar, Ender ^b   Naqvi, Syed Kamran ul Hassan ^c   Yaylim, Ilhan ^b   Ismail, Muhammad ^d  

^a GC UNIVERSITY   (Pakistan)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Department of Electrical Computer Engineering   (Pakistan)

^d INSTITUTE OF BIOMEDICAL AND GENETIC ENGINEERING IBGE   (Pakistan)

Author keywords

Apoptosis; Cancer; MiRNA; Signaling

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA;

ANIMAL; APOPTOSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; RNA, LONG NONCODING;

EID: 84899113500     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.5.1909     Document Type: Short Survey

References (47)

1. Alachkar H, Santhanam R, Harb JG (2013). Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. J Hematol Oncol, 6, 21.
2. Babar IA, Cheng CJ, Booth CJ, et al. (2012). Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci USA, 109, 1695-704.
3. Bai Y, Qiu GR, Zhou F, et al. (2013). Overexpression of DICER1 induced by the upregulation of GATA1 contributes to the proliferation and apoptosis of leukemia cells. Int J Oncol, 42,1317-24.
4. Bertozzi D, Marinello J, Manzo SG, et al. (2014). The natural inhibitor of DNA topoisomerase i, camptothecin, modulates HIF-1aα activity by changing miR expression patterns in human cancer cells. Mol Cancer Ther, 13, 239-48.
5. Chaulk SG, Lattanzi VJ, Hiemer SE, Fahlman RP, Varelas X (2013). The Hippo Pathway Effectors TAZ/YAP regulate dicer expression and miRNA biogenesis through Let-7. J Biol Chem, 289, 1886-91.
6. Chen L, Tang Y, Wang J, Yan Z, Xu R (2013). miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4. Biochem Biophys Res Commun, 435, 745-50.
7. Chiyomaru T, Yamamura S, Fukuhara S, et al. (2013). Genistein inhibits prostate cancer cell growth by targeting miR-34a and Oncogenic HOTAIR. PLoS One, 8, 70372.
8. Feng L, Xie Y, Zhang H, Wu Y (2011). Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650. Biochem Biophys Res Commun, 406, 534-8.
9. Gómez-Cabello D, Adrados I, Gamarra D, et al. (2013). DGCR8-mediated disruption of miRNA biogenesis induces cellular senescence in primary fibroblasts. Aging Cell, 12, 923-31.
10. Guo Y, Tian P, Yang C, et al. (2013). Silencing the doublestranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion. Pharm Res, [Epub ahead of print].
11. Hao J, Zhang S, Zhou Y, et al. (2011). MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun, 406, 552-7.
12. Herbert KM, Pimienta G, Degregorio SJ, Alexandrov A, Steitz JA (2013). Phosphorylation of DGCR8 increases its intracellular stability and induces a progrowth miRNA profile. Cell Rep, 5, 1070-81.
13. Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA (2010). ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA, 107, 1506-11.
14. Jiang Z, Guo J, Xiao B (2010). Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol, 45, 17-23.
15. Johansson J, Berg T, Kurzejamska E, et al. (2013). MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene.
16. Kong W, Yang H, He L, et al. (2008). MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol, 28, 6773-84.
17. Kopp KL, Ralfkiaer U, Gjerdrum LM, et al. (2013). STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle, 12, 1939-47.
18. Li P, Grgurevic S, Liu Z, et al. (2013). Signal transducer and activator of transcription-3 induces MicroRNA-155 expression in chronic lymphocytic leukemia. PLoS One, 8, 64678.
19. Ling N, Gu J, Lei Z, et al. (2013). micro RNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma. Oncol Rep, 30, 2111-8.
20. Liu Q, Chen J, Wang J, et al. (2013). Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Mol Carcinog, [Epub ahead of print].
21. Liu WJ, Zhao YP, Zhang TP, et al. (2003). MLH1 as a Direct Target of MiR-155 and a Potential Predictor of Favorable Prognosis in Pancreatic Cancer. J Gastrointest Surg, 17, 1399-405.
22. Mansour WY, Bogdanova NV, Kasten-Pisula U, et al. (2013). Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma. Radiother Oncol, 106, 147-54.
23. Mraz M, Dolezalova D, Plevova K, et al. (2012). MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood, 119, 2110-3.
24. Neilsen PM, Noll JE, Mattiske S, et al. (2013). Mutant p53 drives invasion in breast tumors through up-regulation of miR-155. Oncogenem, 32, 2992-3000.
25. Pu J, Bai D, Yang X, et al. (2012). Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155. Biochem Biophys Res Commun, 428, 210-5.
26. Qin W, Ren Q, Liu T, Huang Y, Wang J. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. FEBS Lett, 587, 1434-9.
27. Rozovski U, Calin GA, Setoyama T, et al. (2012). Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Mol Cancer, 12, 50.
28. Sandhu SK, Volinia S, Costinean S, et al. (2012). miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model. Proc Natl Acad Sci USA, 109, 20047-52.
29. Sun M, Xia R, Jin F, et al. (2013). Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol, 35, 1065-73.
30. Tang X, Wen S, Zheng D, ET AL. (2013). Acetylation of drosha on the N-terminus inhibits its degradation by ubiquitination. PLoS One, 8, 72503.
31. Xhemalce B, Robson SC, Kouzarides T (2012). Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell, 151, 278-88.
32. Xu TP, Zhu CH, Zhang J, et al. (2013). MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas. Asian Pac J Cancer Prev, 14, 7085-90.
33. Yang L, Lin C, Jin C, et al. (2013), Rosenfeld MG. lncRNAdependent mechanisms of androgen-receptor-regulated gene activation programs. Nature, 500, 598-602.
34. Yang X, Song JH, Cheng Y, et al. (2013). Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut.
35. Yao Q, Sun JG, Ma H, et al. (2014;). Monitoring microRNAs using a molecular beacon in CD133+/ CD338+ human lung adenocarcinoma-initiating A549 Cells. Asian Pac J Cancer Prev, 15, 161-6.
36. Zeng ZL, Li FJ, Gao F, Sun DS, Yao L (2013). Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma. J Surg Oncol, 107, 105-10.
37. Zhang C, Zhao J, Deng H (2013). 17β-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. Mol Cell Biochem, 379, 201-11.
38. Zhang GJ, Xiao HX, Tian HP, et al. (2013). Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression. Int J Mol Med, 31, 1375-80.
39. Zhang X, Li M, Zuo K, et al. (2013). Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-Catenin signaling. J Clin Endocrinol Metab, 98, 1305-13.
40. Zhang X, Zhu W, Zhang J, et al. (2010). MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun, 395, 275-80.
41. Zhang Y, Gong W, Dai S, et al. (2012). Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Mol Cancer Res, 10, 516-22.
42. Zhang Y, Wei W, Cheng N, et al. (2012). Hepatitis C virusinduced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology, 56, 1631-40.
43. Zhang Z, Zhu Z, Watabe K, et al. (2013). Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ, 20, 1558-68.
44. Zhao XD, Zhang W, Liang HJ, Ji WY (2013). Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3. PLoS One, 8, 56395.
45. Zheng SR, Guo GL, Zhai Q, Zou ZY, Zhang W (2013). Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors. Asian Pac J Cancer Prev, 14, 2361-6.
46. Zhong XY, Yu JH, Zhang WG, et al. (2012). MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene, 493, 44-51.
47. Zhou H, Xiao B, Zhou F, (2012). MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers, 17, 104-10.